IQity, the developer of a revolutionary integrated diagnostic and surgical platform for modern ophthalmology, today announced a strategic partnership with Sightpath Medical, the nation's leading ...

Exclusive Worldwide Licensing Agreement with Cella Therapeutics Adds an Array of New Chemical Entities to Visus’ Drug Pipeline Agreement with DelSiTech for Sustained Drug Delivery Platform Allows ...

Eyenovia announces progress on its user-filled Optejet eye drop dispenser, aiming for U.S. regulatory approval in late 2025. Eyenovia, Inc. has made significant advancements in the development of its ...

Chaomu Technology (Beijing) Co. Ltd. has raised nearly ¥100 million (US$14 million) in a series A+ round to develop its ophthalmic medical devices. The proceeds from the financing will be used for the ...

2023 NOV 22 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Business Daily-- Current study results on Information Technology have been published. According to news reporting from ...

The 2026 High Five Awards honor Capital Ophthalmic and four top industry peers for excellence in critical eye care ...

Ophthalmic Consultants of Boston is a referral center for advanced eye care, serving patients throughout Greater Boston, Metrowest, the North Shore, South Shore and Cape Cod. It was the first private ...

SEATTLE--(BUSINESS WIRE)--Visus Therapeutics Inc., a clinical-stage pharmaceutical company focused on developing innovative ophthalmic therapies to improve vision for people around the world, today ...